Intra-Trac® KC
NOBIVAC® Intra-Trac® KC provides protection against the highly contagious canine parainfluenza virus and Bordetella bronchiseptica.
Product Description
NOBIVAC® INTRA-TRAC® KC provides protection against Canine Infectious Tracheobronchitis (“Canine Cough”)
Canine Parainfluenza Virus (modified live virus), Bordetella Bronchiseptica (avirulent live culture).
- Protects against canine parainfluenza virus and
B. bronchiseptica (canine cough) in dogs and puppies86 - Provides rapid onset of protection within 72 hours for B. bronchiseptica
- A small 0.4 mL dose provides for easy administration
- No applicator tip required
Indications:
This product has been shown to be effective for vaccination of healthy dogs 3 weeks of age or older against canine parainfluenza virus and Bordetella bronchiseptica.
NOBIVAC® INTRA-TRAC® KC IS A SAFE CHOICE
- Proven over 99% reaction-free in 1,289-dog field trial86
- Safe for pregnant bitches in all trimesters86
ADMINISTRATION AND DOSAGE
- Intranasal administration only
- 0.4 mL-dose administered directly into 1 nostril
- Historically, annual revaccination has been recommended for this product. The need for this booster has not been established. Contact your veterinarian or manufacturer for more information on revaccination frequency.
- Available in a 25 x 0.4 mL dose presentation
ALSO AVAILABLE IN OTHER FORMULATIONS
DISEASE INFORMATION
Professional Resources and Educational Materials
Keep your clinic and staff informed and aware of diseases and outbreaks.
View More Nobivac® ResourcesInfographic
Pair Up for Protection
When it comes to dogs in social environments, respiratory protection is essential. Use this conversation starter to discuss full respiratory protection with your clients
Digital Assets
Pair Up for Protection Social Media Kit
This vaccination season, use these ready-to-share posts to educate pet parents about the importance of full canine respiratory protection
eBook
Addressing CIV in Your Clinic
Tips and guidelines for your clinic to prevent and manage canine influenza.
References
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global